Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241310732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Chiara Imbesi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Neuroblastoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuroinflammation is an inflammatory response of the nervous tissue mediated by the production of cytokines, chemokines, and reactive oxygen species. Recent studies have shown that an upregulation of immunoproteasome is highly associated with various diseases and its inhibition attenuates neuroinflammation. In this context, the development of non-covalent immunoproteasome-selective inhibitors could represent a promising strategy for treating inflammatory diseases. Novel amide derivatives, KJ3 and KJ9, inhibit the β5 subunit of immunoproteasome and were used to evaluate their possible anti-inflammatory effects in an in vitro model of TNF-α induced neuroinflammation. Differentiated SH-SY5Y and microglial cells were challenged with 10 ng/mL TNF-α for 24 h and treated with KJ3 (1 µM) and KJ9 (1 µM) for 24 h. The amide derivatives showed a significant reduction of oxidative stress and the inflammatory cascade triggered by TNF-α reducing p-ERK expression in treated cells. Moreover, the key action of these compounds on the immunoproteasome was further confirmed by halting the IkB-α phosphorylation and the consequent inhibition of NF-kB. As downstream targets, IL-1β and IL-6 expression resulted also blunted by either KJ3 and KJ9. These preliminary results suggest that the effects of these two compounds during neuroinflammatory response relies on the reduced expression of pro-inflammatory targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, University of Messina, Via C. Valeria, 98125 Messina, Italy.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres, 98166 Messina, Italy.
ORCID-Profile: Natasha Irrera, Giovanni Pallio
Zitieren
APA
Imbesi, C., Ettari, R., Irrera, N., Zappalà, M., Pallio, G., Bitto, A., & Mannino, F. (2023). Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310732
Vancouver
Imbesi C, Ettari R, Irrera N, Zappalà M, Pallio G, Bitto A, et al. Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310732
BibTeX
@article{Imbesi2023,
author = {Imbesi, Chiara and Ettari, Roberta and Irrera, Natasha and Zappalà, Maria and Pallio, Giovanni and Bitto, Alessandra and Mannino, Federica},
title = {Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241310732}
}
EUVIMED